Literature DB >> 17513005

Low prevalence of SV40 in Swiss mesothelioma patients after elimination of false-positive PCR results.

Annemarie Ziegler1, Christian A Seemayer, Marc Hinterberger, Peter Vogt, Colette Bigosch, Oliver Gautschi, Luigi Tornillo, Daniel C Betticher, Holger Moch, Rolf A Stahel.   

Abstract

The association of simian virus 40 (SV40) with malignant pleural mesothelioma is currently under debate. In some malignancies of viral aetiology, viral DNA can be detected in the patients' serum or plasma. To characterize the prevalence of SV40 in Swiss mesothelioma patients, we optimized a real-time PCR for quantitative detection of SV40 DNA in plasma, and used a monoclonal antibody for immunohistochemical detection of SV40 in mesothelioma tissue microarrays. Real-time PCR was linear over five orders of magnitude, and sensitive to a single gene copy. Repeat PCR determinations showed excellent reproducibility. However, SV40 status varied for independent DNA isolates of single samples. We noted that SV40 detection rates by PCR were drastically reduced by the implementation of strict room compartmentalization and decontamination procedures. Therefore, we systematically addressed common sources of contamination and found no cross-reactivity with DNA of other polyomaviruses. Contamination during PCR was rare and plasmid contamination was infrequent. SV40 DNA was reproducibly detected in only 4 of 78 (5.1%) plasma samples. SV40 DNA levels were low and not consistently observed in paired plasma and tumour samples from the same patient. Immunohistochemical analysis revealed a weak but reproducible SV40 staining in 16 of 341 (4.7%) mesotheliomas. Our data support the occurrence of non-reproducible SV40 PCR amplifications and underscore the importance of proper sample handling and analysis. SV40 DNA and protein were found at low prevalence (5%) in plasma and tumour tissue, respectively. This suggests that SV40 does not appear to play a major role in the development of mesothelioma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17513005     DOI: 10.1016/j.lungcan.2007.03.025

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  7 in total

Review 1.  In vitro experimental models of mesothelioma revisited.

Authors:  Anand Singh; Nathanael Pruett; Chuong D Hoang
Journal:  Transl Lung Cancer Res       Date:  2017-06

Review 2.  Malignant mesothelioma: facts, myths, and hypotheses.

Authors:  Michele Carbone; Bevan H Ly; Ronald F Dodson; Ian Pagano; Paul T Morris; Umran A Dogan; Adi F Gazdar; Harvey I Pass; Haining Yang
Journal:  J Cell Physiol       Date:  2012-01       Impact factor: 6.384

3.  Merkel cell polyomavirus is not detected in mesotheliomas.

Authors:  Kishor Bhatia; Rama Modali; James J Goedert
Journal:  J Clin Virol       Date:  2009-12-16       Impact factor: 3.168

Review 4.  Malignant mesothelioma as a difficult interdisciplinary problem.

Authors:  Wojciech Rokicki; Marek Rokicki; Jacek Wojtacha; Mateusz K Rydel
Journal:  Kardiochir Torakochirurgia Pol       Date:  2017-12-20

5.  Fra-1 governs cell migration via modulation of CD44 expression in human mesotheliomas.

Authors:  Maria E Ramos-Nino; Steven R Blumen; Harvey Pass; Brooke T Mossman
Journal:  Mol Cancer       Date:  2007-12-21       Impact factor: 27.401

6.  The Prognostic Role and Relationship between E2F1 and SV40 in Diffuse Large B-Cell Lymphoma of Egyptian Patients.

Authors:  Rehab M Samaka; Hayam A Aiad; Mona A Kandil; Nancy Y Asaad; Nanes S Holah
Journal:  Anal Cell Pathol (Amst)       Date:  2015-10-27       Impact factor: 2.916

7.  Inhibition of cyclin-dependent kinase 7 down-regulates yes-associated protein expression in mesothelioma cells.

Authors:  Jinbai Miao; Hiroyuki Kyoyama; Luwei Liu; Geraldine Chan; Yucheng Wang; Anatoly Urisman; Yi-Lin Yang; Shu Liu; Zhidong Xu; Hu Bin; Hui Li; David M Jablons; Liang You
Journal:  J Cell Mol Med       Date:  2019-11-21       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.